Stay updated on Selpercatinib in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Selpercatinib in Advanced Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe site footer's revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now displays a 403 Forbidden error instead of showing the study content, indicating access is blocked to the NCT03157128 record. This reflects an access-control issue rather than an update to the study data.SummaryDifference23%

- Check34 days agoChange DetectedThe page's revision label updated from v3.6.6 to v3.7.0, indicating an updated version of the page. This is an administrative update rather than a substantive content change.SummaryDifference0.0%

- Check49 days agoChange DetectedA new revision tag, v3.6.6, appears, replacing the prior v3.6.5, indicating a minor update to the page's versioning.SummaryDifference0.0%

- Check55 days agoChange DetectedTwo NIH grant/contract lines for 2017 and 2023 were added to the study record, reflecting funding support for the LIBRETTO-001 study.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, signaling a newer revision of the page content. This change reflects an update to the page's metadata rather than to the study information.SummaryDifference0.0%

Stay in the know with updates to Selpercatinib in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.